Launch prices for new drugs ‘significantly’ exceed inflation, analysis says
Amid intensifying angst over prescription drug prices, a new analysis found that the median net price for 154…
CVS Caremark tells AIDS activists Gilead needs to lower the price of its new HIV drug to get on formularies
For the past three months, CVS Caremark has resisted adding a new Gilead Sciences HIV prevention drug to…
Vega Health raises $4 million to help hospitals adopt AI
Casey Ross covers the use of artificial intelligence in medicine and its underlying questions of safety, fairness, and…
FDA approved fewer drugs in third quarter, analysis finds
The upheaval at the Food and Drug Administration appears to be taking a toll on the pharmaceutical industry,…
FDA announces first nine recipients of priority drug review vouchers
WASHINGTON — The Food and Drug Administration on Thursday announced the first nine recipients of the Commissioner’s National…
As more nurses deliver primary care, Altitude tries to use AI to boost their skills
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.…
Lyra Health launches ‘clinical-grade’ mental health chatbot
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.…
The Apple Watch blood pressure feature lives in a gray area
Welcome to The Workup, a First Opinion column from Vishal Khetpal. As a physician in the age of wearables,…
Mass General Brigham turning to AI to ease primary care doctor shortage
Mass General Brigham has turned to artificial intelligence to address a critical shortage of primary care doctors, launching an…
Startup tech helps Parkinson’s disease patients track symptoms
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.…
Science, bioethics advisers to health agencies are being cast aside
For two years, a panel of scientific experts, clinicians, and patient advocates had been hammering out ways to…
Ex-FDA regulator Peter Marks joins Eli Lilly
WASHINGTON — Peter Marks, the former top vaccine regulator at the Food and Drug Administration, has joined Eli Lilly…